Insider Shareholders with Direct Ownership of Cellectar Biosciences, Inc. (CLRB)
This section provides a comprehensive overview of the insiders with direct ownership of Cellectar Biosciences, Inc. (CLRB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cellectar Biosciences, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Andrei Shustov
Senior Vice President, Medical |
47,856 | 0 | 55,037 $86,408 | 1 |
Dec 08, 2023
Added 46.51%
|
|
Jarrod Longcor
Chief Operating Officer |
72,557 | 0 | 53,141 $83,431 | 2 |
Dec 08, 2023
Added 44.68%
|
|
James V Caruso
President and CEO |
82,733 | 0 | 49,236 $77,300 | 3 |
Dec 08, 2023
Added 45.19%
|
|
Chad J Kolean
Chief Financial Officer |
42,554 | 0 | 42,578 $66,847 | 1 |
Dec 08, 2023
Added 49.99%
|
|
Darrell Shane Lea
Chief Commercial Officer |
39,599 | 0 | 39,599 $62,170 | 1 |
Dec 08, 2023
Added 50.0%
|
|
Douglas J Swirsky
Director |
25,000 | 0 | 25,000 $39,250 | 1 |
Sep 14, 2021
Added 50.0%
|
|
Frederick W Driscoll
Director |
19,417 | 0 | 19,417 $30,484 | 1 |
Sep 03, 2021
Added 50.0%
|
|
Dov Elefant
Chief Financial Officer |
7,407 | 0 | 11,755 $18,455 | 1 |
Dec 28, 2020
Added 38.65%
|